Author

Carles Tolosa

Observed names: C Tolosa, C. Tolosa, CARLOS TOLOSA, Carles Tolosa-Ridao, Carles Tolosa‐Ridao

Institutions: University Hospital Mútua de Terrassa, Mútua Terrassa

Observed institutions: Hospital Virgen de la Luz, University Hospital Mútua de Terrassa, Hospital Clínic de Barcelona, Corporació Sanitària Parc Taulí, Mútua Terrassa, Universitat de Barcelona

ORCID: 0000-0003-0706-9046

Observed ORCID: 0000-0003-0706-9046

OpenAlex ID: A5091384425

Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

2012 · MARIA CARMEN CÉNIT, CARMEN P. SIMEÓN, et al. · The Journal of Rheumatology · 38

Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

2017 · Chatree Chai-Adisaksopha, Alfonso Iorio, et al. · The American Journal of Medicine · 19

EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation

2024 · Carles Tolosa-Ridao, Enric Cascos, et al. · Bone Marrow Transplantation · 16

Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome

2022 · Ana Muntañola, Pablo Mozas, et al. · British Journal of Haematology · 16

Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

2020 · Marc Blondon, David Jimenez, et al. · Journal of Thrombosis and Haemostasis · 16

Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

2019 · Iva Golemi, Lauren Cote, et al. · Journal of Vascular Surgery Venous and Lymphatic Disorders · 13

Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH ‐ TC study

2025 · Carles Tolosa‐Ridao, Mónica Baile González, et al. · British Journal of Haematology · 4

Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes

2026 · Luis Gerardo Rodríguez-Lobato, Anna de Daniel, et al. · Bone Marrow Transplantation · 1

Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experience

2025 · Carles Tolosa-Ridao, Joan Cid, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1

PA-270 Isatuximab in Combination (Isa VRd) in Patients With Newly Diagnosed Multiple Myeloma Not Candidates for Transplant: Clinical Practice Experience in Hospitals in Spain

2026 · María Esther Clavero, Jose Miguel Taboada, et al. · Clinical Lymphoma Myeloma & Leukemia

Pomalidomide, Cyclophosphamide and Dexamethasone ( PCd ): Outcomes in Patients With Double‐ or Triple‐Refractory Multiple Myeloma

2026 · Marta Hidalgo‐Soto, Luis Gerardo Rodríguez‐Lobato, et al. · European Journal Of Haematology

PomCyDex in Relapsed/Refractory Multiple Myeloma: Impact of Prior Refractoriness in a Real-World Setting

2025 · Marta Hidalgo-Soto, Luis Gerardo Rodríguez-Lobato, et al. · Clinical Lymphoma Myeloma & Leukemia

Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia

2024 · Carles Tolosa-Ridao, María Suárez-Lledó, et al. · Bone Marrow Transplantation

Allogeneic Hematopoietic Cell Transplantation with Sequential-Based Conditioning in Refractory / Relapsed Acute Myeloid Leukemia: Experience from a Single Institution

2023 · Carles Tolosa-Ridao, Paola Charry, et al. · Blood

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

2023 · Carles Tolosa-Ridao, Paola Charry, et al. · Blood

Works count: 15

Citation count: 124

H-index: 6

I10-index: 6